Marimed (MRMD) Cash from Investing Activities (2012 - 2026)

Marimed (MRMD) has 15 years of Cash from Investing Activities data on file, last reported at -$753000.0 in Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 554.78% year-over-year to -$753000.0 in Q1 2026; TTM through Mar 2026 was -$2.0 million, a 84.46% increase from a year earlier, with the FY2025 full-year figure at -$1.4 million, up 91.95% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$753000.0, down from -$197000.0 in the prior quarter.
• Over the last five years, Cash from Investing Activities for MRMD reached as high as -$115000.0 in Q1 2025 and fell as low as -$16.7 million in Q2 2022.
• Historically, Cash from Investing Activities has averaged -$4.2 million across 5 years, with a median of -$2.6 million in 2022.
• Across the five-year window, Cash from Investing Activities soared 97.3% in 2025 and slumped 554.78% in 2026, its largest moves.
• Year by year, Cash from Investing Activities stood at -$2.5 million in 2022, then sank by 152.61% to -$6.3 million in 2023, then surged by 81.1% to -$1.2 million in 2024, then soared by 83.58% to -$197000.0 in 2025, then plunged by 282.23% to -$753000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$753000.0 in Q1 2026, -$197000.0 in Q4 2025, and -$514000.0 in Q3 2025.